September 28, 2015 by Chain Drug Review
Darren Karst, EnvisionRx, Rite Aid
2015, Issue 09-28-2015, Issues, News
CAMP HILL, Pa. — Rite Aid Corp. trimmed its full-year earnings guidance to reflect pharmacy margin pressure and lower expectations for same-store sales. The company also pruned its revenue forecast. “Our guidance reflects our expectations for continued reimbursement rate pressure and the benefits from the McKesson purchasing agreement, as well as the anticipated benefits of
September 17, 2015 by Chain Drug Review
EnvisionRx, fiscal 2016 second quarter, John Standley, McKesson, Rite Aid, Wellness Stores
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — Rite Aid Corp. saw revenue surge in its fiscal 2016 second quarter, its first including results for recently acquired pharmacy benefit manager EnvisionRx. Rite Aid said Thursday that sales for the second quarter ended Aug. 29 totaled $7.66 billion, up 17.5% from $6.52 billion a year earlier. For the first time,
August 3, 2015 by Chain Drug Review
David Abelman, EnvisionRx, Frank Sheehy, Health Dialog, Jocelyn Konrad, John Learish, John Standley, Ken Martindale, RediClinic, Rite Aid, Robert Thompson, Tony Montini, Web Golinkin, Wellness Stores, Wilson Lester
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — In a reorganization of key leadership, Rite Aid Corp. has promoted president and chief operating officer Ken Martindale to the newly created position of chief executive officer of Rite Aid stores. The drug chain said late Monday that Martindale, 55, takes the new post effective immediately and will continue to report
July 6, 2015 by Mark Baumgartner and Chain Drug Review
Envision Pharmaceutical Services, EnvisionRx, Frank Sheehy, John Standley, PBM, Rite Aid
2015, Issue 07-06-2015, Issues, News
CAMP HILL, Pa. — Rite Aid has completed its acquisition of Envision Pharmaceutical Services from private investment firm TPG and other shareholders in a transaction valued at about $2 billion, including about $1.8 billion in cash, and around 27.9 million Rite Aid shares. EnvisionRx will operate as a wholly owned subsidiary of Rite Aid under
June 24, 2015 by Chain Drug Review
Envision Pharmaceutical Services, EnvisionRx, Frank Sheehy, John Standley, PBM, pharmacy benefit management, Rite Aid
Business, Leading Headlines, Pharmacy, Retail News
CAMP HILL, Pa. — Rite Aid Corp. has finalized its acquisition of pharmacy benefit management company Envision Pharmaceutical Services. The closing of the deal, valued at about $2 billion, came early in the timetable that Rite Aid initially reported. When the acquisition was announced in February, Rite Aid said it expected to complete the transaction
June 18, 2015 by Chain Drug Review
EnvisionRx, first quarter, fiscal 2016, John Standley, Plenti, RediClinic, Rite Aid, same-store sales, Wellness Store
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — Rite Aid Corp. saw sales edge up and earnings decline for its fiscal 2016 first quarter, and the company for the first time gave full-year guidance that includes its pending acquisition of pharmacy benefit manager EnvisionRx. Rite Aid said Thursday that for the first quarter ended May 30, net income totaled
March 19, 2015 by Chain Drug Review and Chain Drug Review
EnvisionRx, Rite Aid
Business, Leading Headlines, Retail News
CAMP HILL, Pa. — Rite Aid Corp. plans a $1.8 billion bond offering to finance its pending acquisition of pharmacy benefit manager Envision Pharmaceutical Services (EnvisionRx). Rite Aid said late Wednesday that it will offer $1.8 billion of senior unsecured notes due in 2023. Plans call for the offering’s net proceeds, together with other available
March 16, 2015 by Greg Jacobson and Chain Drug Review
EnvisionRx, Frank Sheehy, John Standley, PBM, pharmacy benefits manager, Rite Aid
2015, Issue 03-16-2015, News
CAMP HILL, Pa. — Rite Aid Corp. has broadened and deepened its health care footprint by agreeing to acquire pharmacy benefits manager Envision Pharmaceutical Services (EnvisionRx) for around $2 billion in cash and stock from TPG, a private investment firm. The transaction, which has been approved by the boards of directors of both companies, is
February 13, 2015 by Chain Drug Review and Chain Drug Review
Adam Fein, CVS Health, Drug Channels, EnvisionRx, Fitch Ratings, PBM, Rite Aid
CDR Blog
Rite Aid’s acquisition of PBM EnvisionRx was seen by industry observers as a big plus for the drug chain. Fitch Ratings called the deal “a positive move as it will enable the company to expand its distribution channels by getting a foothold in the specialty and mail-order channels.” “The acquisition is supported by Rite Aid’s improved
February 11, 2015 by Chain Drug Review
EnvisionRx, Frank Sheehy, John Standley, Rite Aid
Retail News
CAMP HILL, Pa. — Rite Aid Corp. has taken another decisive step in its drive to expand its footprint in health care, agreeing to acquire Envision Pharmaceutical Services (EnvisionRx), a full-service pharmacy benefits management company, in a cash-and-stock deal valued at about $2 billion. Rite Aid said Wednesday that it expects the acquisition of EnvisionRx, now